Market Cap

Abingdon Health plc Market Capitalization:

£13.1 Million

GBP as of Jan. 1, 2024

US$16.7 Million

business Abingdon Health plc Company Profile

Abingdon Health plc Main Stock Listing

LSE: ABDX

Market Capitalization History of Abingdon Health plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Diagnostics & Research
Company Market Cap (USD)
Thermo Fisher Scientific $207.62 B
Danaher $171.89 B
Siemens Healthineers AG $66.05 B
DexCom, Inc. $46.50 B
IDEXX Laboratories, Inc. $44.72 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Abingdon Health plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £13.1 M 146.84%
Jan. 1, 2023 £5.3 M -71.64%
Jan. 1, 2022 £18.7 M -83.53%
Jan. 1, 2021 £113.5 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Abingdon Health plc Categories

United Kingdom languages Healthcare languages Diagnostics & Research
United Kingdom Healthcare United Kingdom Diagnostics & Research

Stocks & Indices

Abingdon Health plc has the following listings and related stock indices.


Stock: LSE: ABDX

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.